Biofrontera Pharma completes final steps for FDA new drug application
Monday, June 22, 2015
Biofrontera AG Completes final steps ahead of FDA new drug application in the USA .
* Drug Master File for active substance 5-ALA acknowledged by FDA
* Biofrontera Pharma GmbH registered as medical device manufacturer
* Successful migration to a pharmacovigilance database which complies with FDA requirements
reuters.com
